Search

Your search keyword '"Lotan, C"' showing total 388 results

Search Constraints

Start Over You searched for: Author "Lotan, C" Remove constraint Author: "Lotan, C"
388 results on '"Lotan, C"'

Search Results

1. Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)

2. Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes

4. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

5. Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart Failure (MAGGIC)

6. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

12. Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

13. Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial

14. Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial

16. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

21. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

22. Proceedings from the 2nd European clinical consensus conference for device-based therapies for hypertension: State of the art and considerations for the future

23. Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)

28. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

29. Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future

30. Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSS T2D)

31. Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future

32. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

33. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension

35. Mitral regurgitation etiology affects outcomes in high risk or inoperable patients undergoing transcatheter aortic valve implantation for severe aortic stenosis

41. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

42. Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design

43. Proceedings from the European clinical consensus conference for renal denervation: Considerations on future clinical trial design

47. Real-World Safety and Efficacy of the Endeavor Zotarolimus-Eluting Stent: Early Data From the E-Five Registry.

48. Extended follow-up safety and effectiveness of the Endeavor zotarolimus-eluting stent in real-world clinical practice: Two-year follow-up from the E-Five Registry.

49. Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: Results from the E-Five Registry.

50. One year outcomes in patients implanted with a zotarolimus-eluting stent by age group: Results from the ENDEAVOR-V registry.

Catalog

Books, media, physical & digital resources